BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29062045)

  • 1. Evolution of AF6-RAS association and its implications in mixed-lineage leukemia.
    Smith MJ; Ottoni E; Ishiyama N; Goudreault M; Haman A; Meyer C; Tucholska M; Gasmi-Seabrook G; Menezes S; Laister RC; Minden MD; Marschalek R; Gingras AC; Hoang T; Ikura M
    Nat Commun; 2017 Oct; 8(1):1099. PubMed ID: 29062045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.
    Liedtke M; Ayton PM; Somervaille TC; Smith KS; Cleary ML
    Blood; 2010 Jul; 116(1):63-70. PubMed ID: 20395419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia.
    Manara E; Baron E; Tregnago C; Aveic S; Bisio V; Bresolin S; Masetti R; Locatelli F; Basso G; Pigazzi M
    Blood; 2014 Jul; 124(2):263-72. PubMed ID: 24695851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
    Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M
    Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.
    Deshpande AJ; Chen L; Fazio M; Sinha AU; Bernt KM; Banka D; Dias S; Chang J; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Blood; 2013 Mar; 121(13):2533-41. PubMed ID: 23361907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
    Bégay-Müller V; Ansieau S; Leutz A
    FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AF6/s-afadin is a dual residency protein and localizes to a novel subnuclear compartment.
    Buchert M; Poon C; King JA; Baechi T; D'Abaco G; Hollande F; Hovens CM
    J Cell Physiol; 2007 Jan; 210(1):212-23. PubMed ID: 17013812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.
    Numata A; Kwok HS; Kawasaki A; Li J; Zhou QL; Kerry J; Benoukraf T; Bararia D; Li F; Ballabio E; Tapia M; Deshpande AJ; Welner RS; Delwel R; Yang H; Milne TA; Taneja R; Tenen DG
    Nat Commun; 2018 Apr; 9(1):1622. PubMed ID: 29692408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia.
    Giugliano E; Rege-Cambrin G; Scaravaglio P; Serra A; Wlodarska I; Emanuel B; Saglio G; Hagemeijer A
    Leukemia; 2001 Oct; 15(10):1674-6. PubMed ID: 11587234
    [No Abstract]   [Full Text] [Related]  

  • 10. Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily.
    Linnemann T; Geyer M; Jaitner BK; Block C; Kalbitzer HR; Wittinghofer A; Herrmann C
    J Biol Chem; 1999 May; 274(19):13556-62. PubMed ID: 10224125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis.
    Sano K
    Leuk Lymphoma; 2001 Aug; 42(4):595-602. PubMed ID: 11697487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
    Conn VM; Gabryelska M; Toubia J; Kirk K; Gantley L; Powell JA; Cildir G; Marri S; Liu R; Stringer BW; Townley S; Webb ST; Lin H; Samaraweera SE; Bailey S; Moore AS; Maybury M; Liu D; Colella AD; Chataway T; Wallington-Gates CT; Walters L; Sibbons J; Selth LA; Tergaonkar V; D'Andrea RJ; Pitson SM; Goodall GJ; Conn SJ
    Cancer Cell; 2023 Jul; 41(7):1309-1326.e10. PubMed ID: 37295428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).
    Kundu A; Kowarz E; Marschalek R
    Oncogene; 2021 Oct; 40(40):5902-5912. PubMed ID: 34354240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.
    Marschalek R
    Ann Lab Med; 2016 Mar; 36(2):85-100. PubMed ID: 26709255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
    Kowarz E; Burmeister T; Lo Nigro L; Jansen MW; Delabesse E; Klingebiel T; Dingermann T; Meyer C; Marschalek R
    Leukemia; 2007 Jun; 21(6):1232-8. PubMed ID: 17410185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the rearranged genome and chimeric mRNAs caused by the t(6;11)(q27;q23) chromosome translocation involving MLL in an infant acute monocytic leukemia.
    Akao Y; Isobe M
    Genes Chromosomes Cancer; 2000 Apr; 27(4):412-7. PubMed ID: 10719372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia.
    Maroc N; Morel A; Beillard E; De La Chapelle AL; Fund X; Mozziconacci MJ; Dupont M; Cayuela JM; Gabert J; Koki A; Fert V; Hermitte F
    Leukemia; 2004 Sep; 18(9):1522-30. PubMed ID: 15322560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia.
    Ussowicz M; Jaśkowiec A; Meyer C; Marschalek R; Chybicka A; Szczepański T; Haus O
    Cancer Genet; 2012 May; 205(5):261-5. PubMed ID: 22682626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights to the MLL recombinome of acute leukemias.
    Meyer C; Kowarz E; Hofmann J; Renneville A; Zuna J; Trka J; Ben Abdelali R; Macintyre E; De Braekeleer E; De Braekeleer M; Delabesse E; de Oliveira MP; Cavé H; Clappier E; van Dongen JJ; Balgobind BV; van den Heuvel-Eibrink MM; Beverloo HB; Panzer-Grümayer R; Teigler-Schlegel A; Harbott J; Kjeldsen E; Schnittger S; Koehl U; Gruhn B; Heidenreich O; Chan LC; Yip SF; Krzywinski M; Eckert C; Möricke A; Schrappe M; Alonso CN; Schäfer BW; Krauter J; Lee DA; Zur Stadt U; Te Kronnie G; Sutton R; Izraeli S; Trakhtenbrot L; Lo Nigro L; Tsaur G; Fechina L; Szczepanski T; Strehl S; Ilencikova D; Molkentin M; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2009 Aug; 23(8):1490-9. PubMed ID: 19262598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line.
    Tanabe S; Zeleznik-Le NJ; Kobayashi H; Vignon C; Espinosa R; LeBeau MM; Thirman MJ; Rowley JD
    Genes Chromosomes Cancer; 1996 Apr; 15(4):206-16. PubMed ID: 8703846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.